NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
NCT04960059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2026-03-19
Summary
This study will explore the ability of patients on first line combination immunotherapy to sample cytokines at home. The data from this study will be used to evaluate the feasibility of in-home testing and the ability to analyse patients cytokine profiles retrospectively to help feed the development of further studies.
Conditions
Interventions
- OTHER
-
No intervention
This is an observational study
Sponsors & Collaborators
-
University of Manchester
collaborator OTHER -
The Christie NHS Foundation Trust
lead OTHER
Principal Investigators
-
Donna Graham, MD · The Christie NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-11
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.
NCT05025514 ·Status: UNKNOWN
-
A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors
NCT02318394 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
NCT04910295 ·Status: COMPLETED
-
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
NCT01339000 ·Status: TERMINATED ·Phase: PHASE2
-
Immune Resistance Interrogation Study
NCT04243720 ·Status: RECRUITING
-
Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients
NCT05062525 ·Status: COMPLETED
-
Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies
NCT02880046 ·Status: UNKNOWN
-
Immune Profiling for Cancer Immunotherapy Response
NCT06116032 ·Status: RECRUITING
-
Immuno-Oncology Database and Bioregistry
NCT04656873 ·Status: ACTIVE_NOT_RECRUITING
-
Investigating The Experiences of Patients In Immunotherapy Clinical Trials
NCT05435365 ·Status: NOT_YET_RECRUITING
-
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
NCT00173290 ·Status: UNKNOWN
-
Biological Therapy in Treating Patients With Advanced Cancer
NCT00005956 ·Status: COMPLETED ·Phase: NA
-
NK Cells Infusion for Advanced Malignancies
NCT03619954 ·Status: UNKNOWN ·Phase: PHASE1
-
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
NCT02496520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
NCT03989050 ·Status: WITHDRAWN
-
MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer
NCT04078269 ·Status: COMPLETED ·Phase: PHASE1
-
Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor
NCT04214717 ·Status: UNKNOWN ·Phase: NA
-
Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
NCT06626269 ·Status: RECRUITING ·Phase: NA
-
Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in Immunotherapy
NCT03434912 ·Status: UNKNOWN
-
A Study in Adult Subjects With Select Advanced Solid Tumors
NCT02583165 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Cell Therapy for Advanced Solid Tumors
NCT07260058 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
NCT04283539 ·Status: RECRUITING
-
SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
NCT04929353 ·Status: UNKNOWN ·Phase: NA
-
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
NCT04948619 ·Status: RECRUITING ·Phase: PHASE2
-
The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma
NCT00459069 ·Status: COMPLETED ·Phase: PHASE1